Tarsus Pharmaceuticals (TARS) Inventory (2023 - 2026)

Tarsus Pharmaceuticals' Inventory history runs 4 years deep, the most recent figure standing at $4.6 million for Q1 2026.

• On a quarterly basis, Inventory rose 69.02% year-over-year to $4.6 million in Q1 2026; TTM through Mar 2026 was $4.6 million, a 69.02% increase from a year earlier, with the FY2025 full-year figure at $4.4 million, up 66.87% from the prior year.
• Inventory improved to $4.6 million in Q1 2026 per TARS's latest filing, from $4.4 million in the prior quarter.
• Across five years, Inventory topped out at $4.6 million in Q1 2026 and bottomed at $15000.0 in Q3 2023.
• The 4-year median for Inventory is $3.1 million (2023), against an average of $3.1 million.
• Across the five-year window, Inventory surged 18873.33% in 2024 and tumbled 32.98% in 2025, its largest moves.
• Year by year, Inventory stood at $3.1 million in 2023, then declined by 15.67% to $2.6 million in 2024, then surged by 66.87% to $4.4 million in 2025, then gained by 4.57% to $4.6 million in 2026.
• Per Business Quant, the three latest TARS Inventory figures stand at $4.6 million (Q1 2026), $4.4 million (Q4 2025), and $3.8 million (Q3 2025).